Clinical Trial Update: Study of Subcutaneous Methylnaltrexone (MNTX) in the Treatment of Opioid-Induced Constipation During Rehabilitation After Orthopedic Procedures [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating subcutaneous methylnaltrexone for opioid-induced constipation during rehabilitation after orthopedic surgery has completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-induced Constipation

Drugs mentioned

• Methylnaltrexone (methylnaltrexone)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Opioid-induced Constipation | Phase 2 | Status: COMPLETED | Results posted: 2019-09-04